 |
Srihari S. Naidu is an American physician and Professor of Medicine at New York Medical College who is known for his work on hypertrophic cardiomyopathy including the procedure known as alcohol septal ablation, and for helping to construct the universal diagnostic criteria for cardiogenic shock.
An academic interventional cardiologist, Naidu is an expert in the management of patients with hypertrophic cardiomyopathy, [1] including the minimally-invasive alternative to surgery known as alcohol septal ablation. [2] [3] [4] A co-author on the first ACC/AHA National Guideline on the Diagnosis and Management of Hypertrophic Cardiomyopathy in 2011, he is editor of the international textbook on the disease, [5] [6] runs a Hypertrophic Cardiomyopathy Treatment Center following over 2000 patients, and has personally performed over 275 alcohol septal ablations, believed to be the largest case series of this procedure by a single-operator in the United States. Hypertrophic cardiomyopathy is the most common cause of sudden cardiac death among athletes, and an increasingly recognized cause of heart failure at all ages. [7]
Naidu is Director of the Cardiac Cath Lab and Hypertrophic Cardiomyopathy Center - with offices in Long Island and Westchester - at Westchester Medical Center in Valhalla, NY. He is a two-term Past Member of the American College of Cardiology (ACC) Interventional Scientific Council and has served on the Program Committee for the American Heart Association Annual Scientific Sessions. He is the author of over 200 original scientific manuscripts, and has authored clinical practice guidelines and consensus statements on behalf of the American College of Cardiology (ACC), American Heart Association (AHA) and the Society for Cardiovascular Angiography and Interventions (SCAI), including Chairing the Best Practices in the Cardiac Catheterization Laboratory document since 2012 that outlines operations for cardiac catheterization laboratories in the United States. [8] Naidu is Founder and Past Chair of the Emerging Leader Mentorship (ELM) Program for SCAI (in partnership with ACC and the Cardiovascular Research Foundation), a national leadership pipeline initiated in 2010 that identifies and trains 12 interventional cardiologists every two years. [9] [10]
Naidu is a 2-term Trustee of the Society for Cardiovascular Angiography and Interventions, the primary international professional society for physicians specializing in interventional cardiology, and was inducted into the International Andreas Gruentzig Society in 2016. An alum of the Brown University 8-year Program in Liberal Medical Education, Naidu is Past President of the Alpert Medical School of Brown University Alumni Association Board of Directors, and a Trustee Emeritus of Brown University,. [11]
In 2019, he was elected Governor and President of The New York State Chapter of the American College of Cardiology, and President of The New York Cardiological Society, which he will continue until 2024. In 2021 he was named to the Top 100 Notable Leaders in NY Healthcare in Crain's New York Business for his work in the national cardiovascular response to COVID-19. In 2022, he was elected Secretary of SCAI, is currently Vice President of the Society, and will be President from 2025-2026.
Naidu lives in Manhattan, New York.
Echocardiography, also known as cardiac ultrasound, is the use of ultrasound to examine the heart. It is a type of medical imaging, using standard ultrasound or Doppler ultrasound. The visual image formed using this technique is called an echocardiogram, a cardiac echo, or simply an echo.
Hypertrophic cardiomyopathy is a condition in which muscle tissues of the heart become thickened without an obvious cause. The parts of the heart most commonly affected are the interventricular septum and the ventricles. This results in the heart being less able to pump blood effectively and also may cause electrical conduction problems.
Left ventricular hypertrophy (LVH) is thickening of the heart muscle of the left ventricle of the heart, that is, left-sided ventricular hypertrophy and resulting increased left ventricular mass.
A catheterization laboratory, commonly referred to as a cath lab, is an examination room in a hospital or clinic with diagnostic imaging equipment used to visualize the arteries of the heart and the chambers of the heart and treat any stenosis or abnormality found.
Percutaneous coronary intervention (PCI) is a non-surgical procedure used to treat narrowing of the coronary arteries of the heart found in coronary artery disease. The process involves combining coronary angioplasty with stenting, which is the insertion of a permanent wire-meshed tube that is either drug eluting (DES) or composed of bare metal (BMS). The stent delivery balloon from the angioplasty catheter is inflated with media to force contact between the struts of the stent and the vessel wall, thus widening the blood vessel diameter. After accessing the blood stream through the femoral or radial artery, the procedure uses coronary catheterization to visualise the blood vessels on X-ray imaging. After this, an interventional cardiologist can perform a coronary angioplasty, using a balloon catheter in which a deflated balloon is advanced into the obstructed artery and inflated to relieve the narrowing; certain devices such as stents can be deployed to keep the blood vessel open. Various other procedures can also be performed.
Disopyramide is an antiarrhythmic medication used in the treatment of ventricular tachycardia. It is a sodium channel blocker and is classified as a Class 1a anti-arrhythmic agent. Disopyramide has a negative inotropic effect on the ventricular myocardium, significantly decreasing the contractility. Disopyramide also has an anticholinergic effect on the heart which accounts for many adverse side effects. Disopyramide is available in both oral and intravenous forms, and has a low degree of toxicity.
Septal myectomy is a cardiac surgery treatment for hypertrophic cardiomyopathy (HCM). The open-heart surgery entails removing a portion of the septum that is obstructing the flow of blood from the left ventricle to the aorta.
Alcohol septal ablation (ASA) is a minimally invasive heart procedure to treat hypertrophic cardiomyopathy (HCM).
The history of invasive and interventional cardiology is complex, with multiple groups working independently on similar technologies. Invasive and interventional cardiology is currently closely associated with cardiologists, though the development and most of its early research and procedures were performed by diagnostic and interventional radiologists.
The Canadian Cardiovascular Society (CCS) is the national voice for cardiovascular physicians and scientists in Canada. The CCS is a membership organization that represents more than 1,800 professionals in the cardiovascular field. Its mission is to promote cardiovascular health and care through knowledge translation, professional development and leadership in health policy.
Abdul Jamil Tajik is a Pakistani American physician and medical investigator in the field of cardiovascular diseases. He is listed by the Institute for Scientific Information as a highly cited researcher – one of the top 250 researchers in his field in terms of number of citations.
Hypertrophic cardiomyopathy screening is an assessment and testing to detect hypertrophic cardiomyopathy (HCM).
Transradial catheterization is an endovascular procedure or catheterization procedure performed to diagnose and treat arterial disease. Endovascular procedure can be performed achieving access in to body’s arterial system from either femoral artery, brachial artery or radial artery in the wrist. The transfemoral approach to perform cardiac catheterization has typically been more prevalent in invasive cardiology. But radial access has gained popularity due to technical advances with catheters and lower complication rates than transfemoral access. The European Society of Cardiology and the American Heart Association both support a radial-first approach in acute coronary syndrome.
A diagnosis of myocardial infarction is created by integrating the history of the presenting illness and physical examination with electrocardiogram findings and cardiac markers. A coronary angiogram allows visualization of narrowings or obstructions on the heart vessels, and therapeutic measures can follow immediately. At autopsy, a pathologist can diagnose a myocardial infarction based on anatomopathological findings.
Ulrich Sigwart is a German retired cardiologist known for his pioneering role in the conception and clinical use of stents to keep blood vessels open, and introducing a non-surgical intervention, alcohol septal ablation for the treatment of hypertrophic obstructive cardiomyopathy.
Coronary CT angiography is the use of computed tomography (CT) angiography to assess the coronary arteries of the heart. The patient receives an intravenous injection of radiocontrast and then the heart is scanned using a high speed CT scanner, allowing physicians to assess the extent of occlusion in the coronary arteries, usually in order to diagnose coronary artery disease.
Barry A. Love is an American cardiologist specializing in pediatric and congenital heart problems.
Ashok Seth is an Indian interventional cardiologist, credited with the performance of over 50,000 angiograms and 20,000 angioplasties, which has been included in the Limca Book of Records, a book for achievements and records from an Indian perspective. He is a Fellow of the Royal Colleges of Physicians of London, Edinburgh and Ireland and serves as the chief cardiologist, holding the chairs of the department of cardiovascular sciences and cardiology council at the Fortis Healthcare. Seth, a recipient of the Order of Isabella the Catholic, was honored by the Government of India with the fourth highest Indian civilian award of Padma Shri, in 2003, followed by Padma Bhushan, the third highest Indian civilian award, in 2015.
Alice K. Jacobs is a professor at the Boston University Chobanian & Avedisian School of Medicine who specializes in interventional cardiology, coronary revascularization, and sex-based differences in cardiovascular disease.
Charles Knight MD FRCP OBE is a British professor of cardiology and chief executive of St Bartholomew's Hospital, part of Barts Health NHS Trust.